Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?

Published:2022-07 Issue: Volume:235 Page:108153
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Heng C.K. Matthew,Gilad Nechama,Darlyuk-Saadon Ilona,Wong W.S. Fred,Engelberg David

Funder

National Research Foundation of Singapore

Israel Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference91 articles.

1. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions;Adachi;Journal of Immunology,2000

2. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development;Adams;Molecular Cell,2000

3. Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling;Alford;Journal of Biological Chemistry,2007

4. The many paths to p38 mitogen-activated protein kinase activation in the immune system;Ashwell;Nature Reviews. Immunology,2006

5. Targeted cancer therapy: The next generation of cancer treatment;Baudino;Current Drug Discovery Technologies,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asynchronous Pattern of MAPKs’ Activity during Aging of Different Tissues and of Distinct Types of Skeletal Muscle;International Journal of Molecular Sciences;2024-01-30

2. Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38α;Nature Communications;2023-12-01

3. Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β;International Journal of Molecular Sciences;2023-08-04

4. Progress in the development of kinase inhibitors for treating asthma and COPD;Advances in Pharmacology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3